Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


05.11.2018

1 Acta Cytol
3 Ann Surg Oncol
4 BMC Cancer
1 Br J Cancer
1 Breast Cancer
8 Breast Cancer Res Treat
2 Cancer
1 Cancer Chemother Pharmacol
2 Cancer Epidemiol Biomarkers Prev
2 Cancer Res
2 Clin Breast Cancer
3 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Surg Oncol
3 Int J Cancer
2 Int J Radiat Oncol Biol Phys
1 J Clin Invest
2 PLoS One
2 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. RYU A, Ashimura JI, Nakayama T, Tamaki Y, et al
    Reliability of Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Expression on Breast Cancer Cells Stored in Cellprep(R) Vials.
    Acta Cytol. 2018 Oct 31:1-11. doi: 10.1159/000492501.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. ROOS MM, van Steenhoven JEC, Aalders KC, Schreuder K, et al
    Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment.
    Ann Surg Oncol. 2018 Nov 1. pii: 10.1245/s10434-018-6940.
    PubMed     Text format     Abstract available

  3. BAZAN JG, White JR
    ASO Author Reflections: Shifting the Focus of pT1-2pN1 Breast Cancer: Are We Evaluating the Right Endpoint in Tailoring Adjuvant Radiation Therapy Recommendations?
    Ann Surg Oncol. 2018 Oct 30. pii: 10.1245/s10434-018-6986.
    PubMed     Text format    

  4. ALTMAN AM, Marmor S
    ASO Author Reflections: 21-Gene Recurrence Scores in Male Breast Cancer.
    Ann Surg Oncol. 2018 Oct 29. pii: 10.1245/s10434-018-6951.
    PubMed     Text format    


    BMC Cancer

  5. LUHTALA S, Staff S, Kallioniemi A, Tanner M, et al
    Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
    BMC Cancer. 2018;18:1045.
    PubMed     Text format     Abstract available

  6. FISH EJ, Irizarry KJ, DeInnocentes P, Ellis CJ, et al
    Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    BMC Cancer. 2018;18:832.
    PubMed     Text format     Abstract available

  7. MENG M, Xue H, Lei J, Wang Q, et al
    A novel approach to monitoring the efficacy of anti-tumor treatments in animal models: combining functional MRI and texture analysis.
    BMC Cancer. 2018;18:833.
    PubMed     Text format     Abstract available

  8. GASS P, Lux MP, Rauh C, Hein A, et al
    Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer.
    BMC Cancer. 2018;18:1051.
    PubMed     Text format     Abstract available


    Br J Cancer

  9. MCGREGOR RJ, Chau YY, Kendall TJ, Artibani M, et al
    WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer.
    Br J Cancer. 2018 Oct 30. pii: 10.1038/s41416-018-0317.
    PubMed     Text format     Abstract available


    Breast Cancer

  10. HU K, He P, Peng Q, Zhong X, et al
    OFS plus AI or SERM vs. SERM alone in premenopausal women with hormone receptor-positive breast cancer: a prospective cohort study using the real-world database.
    Breast Cancer. 2018 Oct 26. pii: 10.1007/s12282-018-0929.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  11. SZOSTAKOWSKA M, Trebinska-Stryjewska A, Grzybowska EA, Fabisiewicz A, et al
    Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals.
    Breast Cancer Res Treat. 2018 Nov 1. pii: 10.1007/s10549-018-5023.
    PubMed     Text format     Abstract available

  12. HENG YJ, Wang J, Ahearn TU, Brown SB, et al
    Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
    Breast Cancer Res Treat. 2018 Nov 1. pii: 10.1007/s10549-018-5034.
    PubMed     Text format     Abstract available

  13. YOON TI, Kwak BS, Yi OV, Kim S, et al
    Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Breast Cancer Res Treat. 2018 Oct 30. pii: 10.1007/s10549-018-5031.
    PubMed     Text format     Abstract available

  14. MASKARINEC G, Shvetsov YB, Conroy SM, Haiman CA, et al
    Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort.
    Breast Cancer Res Treat. 2018 Oct 26. pii: 10.1007/s10549-018-5025.
    PubMed     Text format     Abstract available

  15. WALTER KR, Ford ME, Gregoski MJ, Kramer RM, et al
    Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.
    Breast Cancer Res Treat. 2018 Oct 27. pii: 10.1007/s10549-018-4992.
    PubMed     Text format     Abstract available

  16. CAO S, Zhou J, Zhu Z, Wei F, et al
    Adult weight change and the risk of pre- and postmenopausal breast cancer in the Chinese Wuxi Exposure and Breast Cancer Study.
    Breast Cancer Res Treat. 2018 Oct 27. pii: 10.1007/s10549-018-5016.
    PubMed     Text format     Abstract available

  17. RODRIGUES-FERREIRA S, Nehlig A, Monchecourt C, Nasr S, et al
    Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.
    Breast Cancer Res Treat. 2018 Oct 27. pii: 10.1007/s10549-018-5026.
    PubMed     Text format     Abstract available

  18. VALLET S, Fan F, Malvestiti S, Pecherstorfer M, et al
    Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
    Breast Cancer Res Treat. 2018 Oct 29. pii: 10.1007/s10549-018-5022.
    PubMed     Text format     Abstract available


    Cancer

  19. KALINSKY K, O'Regan RM
    Lymph node involvement: Positive about the role of the recurrence score in estrogen-driven breast cancer?
    Cancer. 2018 Nov 2. doi: 10.1002/cncr.31814.
    PubMed     Text format    

  20. GREENWALD MK, Ruterbusch JJ, Beebe-Dimmer JL, Simon MS, et al
    Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.
    Cancer. 2018 Nov 2. doi: 10.1002/cncr.31798.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  21. ESIN E, Oksuzoglu B, Bilici A, Cicin I, et al
    Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes.
    Cancer Chemother Pharmacol. 2018 Oct 30. pii: 10.1007/s00280-018-3712.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  22. MORMILE R
    Metformin Therapy and Breast Cancer Incidence and Mortality-Letter.
    Cancer Epidemiol Biomarkers Prev. 2018;27:1384.
    PubMed     Text format    

  23. MOEN EL, Kapadia NS, O'Malley AJ, Onega T, et al
    Evaluating breast cancer care coordination at a rural National Cancer Institute Comprehensive Cancer Center using network analysis and geospatial methods.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 30. pii: 1055-9965.EPI-18-0771.
    PubMed     Text format     Abstract available


    Cancer Res

  24. NILCHIAN A, Johansson J, Ghalali A, Travica Asanin S, et al
    CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
    Cancer Res. 2018 Nov 1. pii: 0008-5472.CAN-18-1742.
    PubMed     Text format     Abstract available

  25. LI J, Ugalde-Morales E, Wen WX, Decker B, et al
    Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer.
    Cancer Res. 2018;78:6329-6338.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  26. HSU W, Zhou X, Petruse A, Chau N, et al
    Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases.
    Clin Breast Cancer. 2018 Sep 5. pii: S1526-8209(18)30258.
    PubMed     Text format     Abstract available

  27. KOWALCZYK R, Nowosielski K, Cedrych I, Krzystanek M, et al
    Factors Affecting Sexual Function and Body Image of Early-Stage Breast Cancer Survivors in Poland: A Short-Term Observation.
    Clin Breast Cancer. 2018 Sep 21. pii: S1526-8209(18)30474.
    PubMed     Text format     Abstract available


    Clin Cancer Res


  28. Correction: Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer.
    Clin Cancer Res. 2018;24:5486.
    PubMed     Text format    


  29. Correction: MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR(+)/HER2(-) Metastatic Breast Cancer.
    Clin Cancer Res. 2018;24:5485.
    PubMed     Text format    

  30. WANG Z, Liu Q, Wilson CL, Easton J, et al
    Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE).
    Clin Cancer Res. 2018 Oct 26. pii: 1078-0432.CCR-18-1775.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  31. QUAYLE LA, Ottewell PD, Holen I
    Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention.
    Clin Exp Metastasis. 2018 Oct 30. pii: 10.1007/s10585-018-9946.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  32. HELFGOTT, Mittlbock, Miesbauer, Moinfar, et al
    The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
    Eur J Surg Oncol. 2018 Oct 10. pii: S0748-7983(18)31367.
    PubMed     Text format     Abstract available


    Int J Cancer

  33. JOHANSSON ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, et al
    Breast cancer-specific survival by clinical subtype after seven years follow-up of young and elderly women in a nationwide cohort.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31950.
    PubMed     Text format     Abstract available

  34. VAN MAAREN MC, de Munck L, Strobbe LJ, Sonke GS, et al
    10-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study.
    Int J Cancer. 2018 Oct 28. doi: 10.1002/ijc.31914.
    PubMed     Text format     Abstract available

  35. SUN L, Sadique Z, Dos-Santos-Silva I, Yang L, et al
    Cost-effectiveness of Breast Cancer Screening Programme for Women in Rural China.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31956.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  36. DESELM C, Yang TJ, Cahlon O, Tisnado J, et al
    A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Oct 24. pii: S0360-3016(18)33908.
    PubMed     Text format     Abstract available

  37. JACOBSE JN, Duane FK, Boekel NB, Schaapveld M, et al
    Radiation Dose-Response For Risk Of Myocardial Infarction In Breast Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2018 Oct 29. pii: S0360-3016(18)33914.
    PubMed     Text format     Abstract available


    J Clin Invest

  38. CHERNIKOVA SB, Nguyen RB, Truong JT, Mello SS, et al
    Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.
    J Clin Invest. 2018 Oct 29. pii: 87191. doi: 10.1172/JCI87191.
    PubMed     Text format     Abstract available


    PLoS One

  39. ROCHA-BRISCHILIARI SC, Andrade L, Nihei OK, Brischiliari A, et al
    Spatial distribution of breast cancer mortality: Socioeconomic disparities and access to treatment in the state of Parana, Brazil.
    PLoS One. 2018;13:e0205253.
    PubMed     Text format     Abstract available

  40. SEMLALI A, Almutairi M, Rouabhia M, Reddy Parine N, et al
    Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population.
    PLoS One. 2018;13:e0203376.
    PubMed     Text format     Abstract available


    Radiology

  41. PINKER K
    Beyond Breast Density: Radiomic Phenotypes Enhance Assessment of Breast Cancer Risk.
    Radiology. 2018 Oct 30:182296. doi: 10.1148/radiol.2018182296.
    PubMed     Text format    

  42. KONTOS D, Winham SJ, Oustimov A, Pantalone L, et al
    Radiomic Phenotypes of Mammographic Parenchymal Complexity: Toward Augmenting Breast Density in Breast Cancer Risk Assessment.
    Radiology. 2018 Oct 30:180179. doi: 10.1148/radiol.2018180179.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: